Trafficking of MHC class II molecules in the late secretory pathway
about
The HLA-DRalpha chain is modified by polyubiquitinationIi-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines.Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinaseThe effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCsThe Third Way: Progress on pathways of antigen processing and presentation by CD1.The major histocompatibility complex origin.The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.Exogenous Thyropin from p41 Invariant Chain Diminishes Cysteine Protease Activity and Affects IL-12 Secretion during Maturation of Human Dendritic CellsRight place, right time, right peptide: DO keeps DM focused.T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes.MR1 uses an endocytic pathway to activate mucosal-associated invariant T cellsCompetition model for upregulation of the major histocompatibility complex class II-associated invariant chain by human immunodeficiency virus type 1 NefMHC class II transport at a glanceSalmonella regulates polyubiquitination and surface expression of MHC class II antigens.Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.MHC II molecules and invariant chain reside in membranes distinct from conventional lipid rafts.AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes.Predictor for the effect of amino acid composition on CD4+ T cell epitopes preprocessing.The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface.Immunogenicity of calreticulin-bound murine leukemia virus glycoprotein gp90.Comprehensive analysis of medaka major histocompatibility complex (MHC) class II genes: implications for evolution in teleosts.Role of the major histocompatibility complex class II transmembrane region in antigen presentation and intracellular trafficking.Slow degradation in phagocytic astrocytes can be enhanced by lysosomal acidification.Formation of COPII vesicleFusion of COPII vesicle with Golgi complexTransport of MHC II:Ii complex along Golgi to TGNDifferential post-translational modification of CD63 molecules during maturation of human dendritic cells
P2860
Q24312515-5CF1CD1E-357E-41E3-B0B7-4E1AE7D24E94Q30359230-C8121443-570A-4045-9DA9-FA833EDF87AFQ33619173-6D070A12-E2F0-406E-BBC0-F819B115E13BQ33763110-5E47D79B-7C2C-440D-BF09-20689EE49F70Q34179888-555A685B-D44E-4017-B2BD-D2494A946198Q34412690-93FF93FD-5B2F-4678-833B-76501F00DA16Q35143899-139052D0-C1F5-4315-8FAC-E9D452E52F79Q35798152-9D44D89E-7A4E-42AF-A2A3-8B766AE4847DQ35806883-E32B794E-8FC9-4000-87BB-5FD8A05F88F0Q35821240-C7B9BE38-DDFC-4AF5-91FA-97A24D8B7BB5Q35951395-C388D8AC-A531-4F76-9882-7DAC9E3A4CA2Q36266508-6B1D0159-F0A6-4434-95DD-F5E6E197450FQ36439289-059D0E38-BBBB-4CE7-A3BB-A70A49E89AE1Q36640043-32E9BEF7-8B21-429E-9765-10B3B3D16897Q36845640-057F1523-339D-4DE0-9E36-B47645171903Q37271553-BB5AD121-91CA-4758-AFCF-F61637FE9F04Q37291725-AB3F6A05-E3FC-49EB-AFBB-A8272D5F48DBQ37389304-D3155200-584B-48BE-B638-3FB01F3645DAQ40365535-204D9DE9-F919-415C-AF78-244D7854B1D9Q40450171-0DE00F00-81C2-430E-8436-24FBFD8558B7Q40467039-2E325EB8-25A9-4706-BAED-09560535EB56Q41829565-7AF7A990-44E5-4FEF-AA3A-45F4620983D2Q45421005-65B67609-C11C-488F-9957-37DDD74CA00EQ45835209-EE451E0E-A42E-4E67-8F1A-78C4FE92A3F7Q47933613-3350EB1B-4881-449C-B72F-9863C4469597Q48117841-AED6B331-F3B6-45E8-BBE3-48869749A294Q50291577-E29480AA-9DF3-48BE-BEFA-FAC38438E1A8Q50291578-60E35449-2784-4704-8F41-ED3FEA33E7A5Q50291579-DD30CE19-8AC2-44E2-A652-484A3E23F9D0Q57371125-8A32D1E4-121C-4B9F-91F1-73C038FAB0E3
P2860
Trafficking of MHC class II molecules in the late secretory pathway
description
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Februar 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/02/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/02/01)
@nl
наукова стаття, опублікована в лютому 2002
@uk
مقالة علمية (نشرت في فبراير 2002)
@ar
name
Trafficking of MHC class II molecules in the late secretory pathway
@ast
Trafficking of MHC class II molecules in the late secretory pathway
@en
Trafficking of MHC class II molecules in the late secretory pathway
@nl
type
label
Trafficking of MHC class II molecules in the late secretory pathway
@ast
Trafficking of MHC class II molecules in the late secretory pathway
@en
Trafficking of MHC class II molecules in the late secretory pathway
@nl
prefLabel
Trafficking of MHC class II molecules in the late secretory pathway
@ast
Trafficking of MHC class II molecules in the late secretory pathway
@en
Trafficking of MHC class II molecules in the late secretory pathway
@nl
P1476
Trafficking of MHC class II molecules in the late secretory pathway
@en
P2093
Elizabeth M. Hiltbold
Paul A. Roche
P356
10.1016/S0952-7915(01)00295-3
P577
2002-02-01T00:00:00Z